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The striatum plays a key role in mediating the acute and chronic effects of addictive drugs,
with drugs of abuse causing long-lasting molecular and cellular alterations in both dorsal
striatum and nucleus accumbens (ventral striatum). Despite the wealth of research on the
biological actions of abused drugs in striatum, until recently, the distinct roles of the stria-
tum’s two major subtypes of medium spiny neurons (MSNs) in drug addiction remained
elusive. Recent advances in cell-type-speciﬁc technologies, including ﬂuorescent reporter
mice, transgenic, or knockout mice, and viral-mediated gene transfer, have advanced the
ﬁeld toward a more comprehensive understanding of the two MSN subtypes in the long-
term actions of drugs of abuse. Here we review progress in deﬁning the distinct molecular
and functional contributions of the two MSN subtypes in mediating addiction.
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INTRODUCTION
Drugs of abuse exert potent molecular and cellular alterations in
both dorsal striatum (dStr) and ventral striatum (nucleus accum-
bens, NAc), and many of these changes occur in medium spiny
neurons (MSNs), the principal projection neurons in dStr and
NAc, which account for 90–95% of all neurons in these regions.
However, researchers have until recently been unable to clearly
deﬁne the differential role of the two MSN subtypes in addiction-
related phenomena. The two MSN subtypes are differentiated by
their enrichment of dopamine receptor 1 (D1) or dopamine recep-
tor 2 (D2) as well as several other genes (Gerfen and Young, 1988;
Gerfen et al., 1990; Le Moine et al., 1990, 1991; Bernard et al.,
1992; Ince et al., 1997; Lobo et al., 2006, 2007; Heiman et al.,
2008; gensat.org) and by their distinct projections through the
cortico-basal ganglia pathway (the direct vs. indirect pathways;
Gerfen, 1984, 1992). Early work suggested that drugs of abuse
exert most inﬂuence on the D1+MSNs, with the use of numerous
dopamine receptor agonists and antagonists providing important
insight into the functional and molecular roles of each MSN in
drug reward behaviors (Self, 2010). However, current cell-type-
speciﬁc methodologies, including ﬂuorescent reporter mice that
express GFP under D1 or D2 bacterial artiﬁcial chromosomes
(BACs; Gong et al., 2003; Valjent et al., 2009; gensat.org), con-
ditional mouse models such as the use of tetracycline-regulated
inducible transgenic mice (Chen et al., 1998; Kelz et al., 1999), and
transgenicmice expressingCre-recombinase usingD1 orD2 BACs,
yeast artiﬁcial chromosomes (YACs), or knock-in mice (Gong
et al., 2007; Lemberger et al., 2007; Heusner et al., 2008; Park-
itna et al., 2009; Valjent et al., 2009; Bateup et al., 2010; Lobo et al.,
2010; gensat.org) as well as cell-type-speciﬁc viral-mediated gene
transfer (Cardin et al., 2010; Hikida et al., 2010; Lobo et al., 2010;
Ferguson et al., 2011), have provided profound new insight into
the precise molecular underpinnings of each MSN subtype and
their regulation by drugs of abuse (Table 1).
Recent ﬁndings support the conclusion of a more predominate
role for D1+ MSNs in producing the reinforcing and sensitiz-
ing effect of drugs of abuse, with most robust molecular changes
occurring in theseMSNs. For instance, acute exposure to psychos-
timulants potently induces numerous signaling molecules includ-
ing FosB, ERK, c-Fos, and Zif268 in theD1+MSNs,while repeated
cocaine preferentially induces FosB and alters GABA receptor
and other ion channel subunits in this cell-type as well (Robertson
et al., 1991; Young et al., 1991; Berretta et al., 1992; Cenci et al.,
1992; Moratalla et al., 1992; Hope et al., 1994; Bertran-Gonzalez
et al., 2008; Heiman et al., 2008). Furthermore, disrupting or over-
expressing speciﬁcmolecules, such asFosB,DARPP-32,orNr3c1
(the glucocorticoid receptor), in D1+MSNs typically mimics the
drug-related behaviors observed when these alterations are made
in a non-cell-type-speciﬁc manner, while disrupting such genes
in D2+MSNs often causes an opposite response (Fienberg et al.,
1998; Kelz et al., 1999; Deroche-Gamonet et al., 2003; Zachariou
et al., 2006; Ambroggi et al., 2009; Bateup et al., 2010). Nonethe-
less, we cannot rule out an important contribution of the D2+
MSNs in adaptations to drugs of abuse, because cocaine exposure
alters gene expression in bothMSN subtypes (Heiman et al., 2008)
and D2-receptor agonists and antagonists exert potent effects in
behavioral assays (Self, 2010). Indeed, recent ﬁndings show that
molecular signaling adaptations in D2+ MSNs potently modify
an animal’s behavioral response to drugs of abuse (Lobo et al.,
2010). The latter ﬁndings showed that loss of TrkB (the receptor
for BDNF) inD2+MSNs results in similar behavioral responses to
cocaine as total TrkB knockout from the NAc, showing for the ﬁrst
time a selective dominant role for a molecular pathway in D2+
MSNs in mediating the effects of drugs of abuse.
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Table 1 | Effects of cell-type-specific genetic manipulation in D1+ and D2+MSNs in drug addiction models.
Gene/function
manipulated
Cell-type Method Effects mediated by drugs of abuse References
NR1 (NMDA) subunit D1 Mutated NR1
knocked into the D1
locus
Diminished cocaine sensitization and CPP Heusner and Palmiter (2005)
NR1 (NMDA) subunit D1 D1-Cre knockout Attenuated amphetamine sensitization Beutler et al. (2011)
mGluR5 D1 mGluR5 shRNA
driven under D1
BAC
Attenuated cue-induced cocaine seeking Novak et al. (2010)
Acetylcholine
muscarinic receptor
4 (M4)
D1 D1-Cre knockout Enhanced behavioral sensitization to
cocaine and amphetamine
Jeon et al. (2010)
Cannabinoid receptor
1 (CB1)
D1 D1-Cre knockout Blunted response to THC Monory et al. (2007)
Glucocorticoid
receptor nuclear
receptor 3c1 (Nr3c1)
D1 D1-Cre knockout Diminished cocaine self-administration Ambroggi et al. (2009)
BDNF receptor (TrkB) D1 D1-Cre knockout Enhanced cocaine sensitization and CPP Lobo et al. (2010)
BDNF receptor (TrkB) D2 D2-Cre knockout Diminished cocaine sensitization and CPP Lobo et al. (2010)
c-Fos D1 D1-Cre knockout Diminished cocaine sensitization,
diminished cocaine extinction
Zhang et al. (2006)
AFosB D1 Overexpression
with tetracycline
inducible D1 mouse
line
Enhanced morphine CPP, enhanced
morphine tolerance, diminished morphine
analgesia, enhanced cocaine sensitization
and CPP
Zachariou et al. (2006),
Kelz et al. (1999)
DARPP-32 D1 D1-Cre knockout Diminished cocaine sensitization Bateup et al. (2010)
DARPP-32 D2 D2-Cre knockout Enhanced cocaine sensitization Bateup et al. (2010)
ChR2, light-activated
neuronal activity
D1 Conditional AAV
viruses+D1-Cre
Enhanced cocaine CPP Lobo et al. (2010)
ChR2, light-activated
neuronal activity
D2 Conditional AAV
viruses+D2-Cre
Diminished cocaine sensitization Lobo et al. (2010)
Tetanus toxin light
chain inhibited
synaptic
transmission
D1 Overexpressed with
AAV virus with
substance P
promoter
Diminished cocaine CPP and sensitization Hikida et al. (2010)
Tetanus toxin light
chain inhibited
synaptic
transmission
D2 Overexpressed with
AAV virus with
enkephalin
promoter
No change in CPP, slight decrease in
sensitization
Hikida et al. (2010)
hM4D DREADD
inhibit neuron ﬁring
D1 Overexpressed with
HSV virus with
dynorphin promoter
Diminished amphetamine sensitization Ferguson et al. (2011)
hM4D DREADD
inhibit neuron ﬁring
D2 Overexpressed with
HSV virus with
enkephalin
promoter
Enhanced amphetamine sensitization Ferguson et al. (2011)
Inducible diptheria
toxin receptor –
ablates cells
D2 Overexpressed with
A2A-Cre
Enhanced amphetamine CPP Durieux et al. (2009)
Finally, recent literature reveals that the twoMSNs exert antag-
onistic effects in drug-related behaviors, where activation of D1+
MSNs or inhibition of D2+ MSNs enhances an animal’s sensi-
tivity to a drug of abuse (Hikida et al., 2010; Lobo et al., 2010;
Ferguson et al., 2011). These ﬁndings are consistent with oppos-
ing roles of the two MSNs and their direct vs. indirect pathways
in the basal ganglia in motor behaviors (Alexander et al., 1986;
Albin et al., 1989; Graybiel, 2000; Kravitz et al., 2010). This recent
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literature is in accordwith the general idea that dopaminergic neu-
rotransmission, which is activated by all drugs of abuse, facilitates
glutamatergic activation of D1+ MSNs while inhibiting gluta-
matergic activation of D2+ MSNs through its actions on D1 vs.
D2 dopamine receptors (Figure 1). In this review, we address the
current knowledge of the distinctmolecular signaling exhibited by
these two MSN subtypes in relation to their functional roles and
responses to drugs of abuse.
DOPAMINE RECEPTOR SIGNALING IN D1 VS. D2 MSNs
As already noted, all drugs of abuse activate dopaminergic input
to the NAc and related limbic brain regions (Volkow et al., 2004;
Wise, 2004; Nestler, 2005). For instance, psychostimulants such as
cocaine or amphetamine act directly on the dopaminergic reward
pathway by interfering with the dopamine transporter: cocaine
blocks the transporter and amphetamine reverses the transporter,
both actions resulting in a build up of dopamine in the synapse
which can activate downstreamdopamine receptors on target neu-
rons (Figure 1). The twoMSNs are most notably differentiated by
their enrichment of D1 vs. D2-receptors although single-cell RT-
PCR studies reveal thatD1+MSNs express low levels of theD2-like
receptor, D3 and D2+ MSNs express low levels of the D1-like
receptor, D5 (Surmeier et al., 1996). The two MSNs require gluta-
matergic innervation to drive neural activity; dopamine oppositely
modulates these functional responses via stimulation of distinct
dopamine receptor subtypes: by positively modulating excitatory
glutamatergic input through D1 receptor signaling via Gs or Golf,
which stimulates adenylyl cyclase leading to increased PKA activ-
ity, whereas dopamine negatively modulates this input through
D2-receptor signaling via Gi and Go which inhibit adenylyl cyclase
causing decreased PKA activity (Surmeier et al., 2007; Gerfen and
Surmeier, 2011). In reality, each receptor exerts complex effects on
many additional downstream signaling pathways. At rest, the two
MSN subtypes are generally inhibited, they are in what researchers
have termed the down-state. Excitatory glutamatergic synaptic
activity can release the MSNs from this down-state and shift them
into a more depolarized state (the up-state). Dopamine oppo-
sitely modulates the excitatory glutamatergic shift to the up-state.
D1 activation of PKA enhances Cav1 L-type Ca2+ channel activ-
ity, decreases somatic K+ channel activity, and downregulates
Cav2 Ca2+ channels that control activation of Ca2+ dependent,
small-conductance K+ (SK) channels, resulting in increased spik-
ing in these MSNs (Surmeier et al., 2007; Gerfen and Surmeier,
2011). In contrast, D2 signaling inhibits the up-state transition,
thereby preventing increased spiking, via reduction of Cav1 L-
type Ca2+ channel activity and Nav1 Na+ channel activity while
increasing K+ channel currents (Surmeier et al., 2007; Gerfen and
Surmeier, 2011; Figure 1). Such opposite alterations in the two
MSNs suggest that increased dopamine signaling elicited by drugs
of abuse should enhance glutamatergic activation of D1+ MSNs
and reduce glutamatergic activation of D2+ MSNs. In reality,
such responses are far more varied and complex for reasons that
remain poorly understood. This topic will be addressed further
below.
The role of dopamine receptors in drug abuse is complex
and often elusive (Self, 2010). There is an abundance of litera-
ture on the role of D1 and D2-receptor agonists and antagonists
in modulating rewarding properties and self-administration of
drugs of abuse, however, the results differ depending on the
type of agonist/antagonist used, the type of delivery (systemic
vs. brain region-speciﬁc), and the timing of the treatment (Self,
2010). Such results are further confounded by non-striatal spe-
ciﬁc effects, such as the contribution of pre-synaptic D2-receptors
from the VTA or presence of D1 receptors in many other lim-
bic regions, and the lack of speciﬁcity of the agonists/antagonists
utilized as well as the expression of D1-like and D2-like recep-
tors in both MSN subtypes as noted earlier. In general, it is
thought that D1 receptors play a more predominant role in the
FIGURE 1 | All drugs of abuse increase dopamine signaling in striatum,
which can differentially modulate glutamatergic activity in the two MSN
subtypes. In particular, cocaine binds to the dopamine transporter preventing
dopamine reuptake into the terminals of VTA dopamine neurons. Activation of
Gs/olf coupled D1 receptors enhances PKA activity and alters Ca2+ and K+
conductances to enhance the glutamate mediated "up-state" in these MSNs.
In contrast, activation of Gi/Go D2-receptors diminishes PKA activity and alters
Ca2+, Na+, and K+ conductances to diminish the glutamate mediated
“up-state.” This shifts these MSNs back to their resting “down-state.”
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primary rewarding properties of drugs of abuse, whereas D2-
receptors play a role in drug seeking mechanisms (Self et al., 1996;
Self, 2010). Studies with D1 receptor and D2-receptor knock-
out mice provide some insight into the role of these receptors
in the two MSNs. D1 knockout mice show a blunted induction
of immediate early genes (IEGs) c-Fos and Zif268 in response
to cocaine, a diminished response to psychostimulant-induced
locomotor activity but with no alterations in cocaine-conditioned
place preference (CPP) – an indirect measure of drug reward, and
diminished cocaine self-administration and ethanol consumption
(Miner et al., 1995; Drago et al., 1996; Crawford et al., 1997; El-
Ghundi et al., 1998; Caine et al., 2007). D2 knockout mice display
diminished rewarding effects to opiates and cocaine as well as
decreased ethanol consumption but no reduction in cocaine tak-
ing (Maldonado et al., 1997; Cunningham et al., 2000; Risinger
et al., 2000; Caine et al., 2002; Chausmer et al., 2002; Elmer et al.,
2002; Welter et al., 2007). Such data support important roles for
D1 and D2-receptors in the two MSNs in multiple aspects of
drug abuse, however, the knockouts lack striatal speciﬁcity and
occur early in development, thus one cannot rule out other brain
regions and cell-types and developmental factors in mediating
these behaviors. Finally, decreased levels of D2/D3 receptors in
striatum, as visualized by brain imaging, has become a com-
mon marker of addiction in human patients especially during
periods of withdrawal (Volkow et al., 2009). Rodents receiving
viral-mediated gene transfer of D2-receptors to the NAc display
attenuated cocaine self-administration and ethanol consumption
(Thanos et al., 2004, 2008). These studies were not performed in
a cell-type-speciﬁc manner, so we cannot rule out the possible
effect of D2-receptor overexpression inﬂuencing D1+MSNs. This
collection of data emphasizes the need to move to more selective
approaches, including cell-type-speciﬁc, region-speciﬁc, and even
temporally speciﬁc manipulations of the dopamine receptors to
better elucidate their functional roles in the two MSN subtypes in
drug addiction.
Finally, it has been reported recently that D2-GFP homozy-
gote BAC transgenic mice display increased expression levels of
the D2-receptor in striatum and enhanced behavioral sensitivity
and dopamine signaling to D2 agonists. Moreover, both homozy-
gotes and hemizygotes exhibit blunted behavioral responses to
cocaine (Kramer et al., 2011). This study highlights the need
to perform thorough characterization of D1 and D2 ﬂuores-
cent reporter and Cre driver lines. However, the majority of the
data collected in this study used homozygotes, which is not the
ideal experimental genotype since 5–10% of transgene integra-
tions result in insertional mutations (Meisler, 1992); therefore,
the hemizygote genotype is the more reliable experimental geno-
type. Additionally, this study did not use littermate wildtype
controls but used controls on a similar background (Swiss Web-
ster) obtained from Taconic, while their transgenic lines were
obtained from GENSAT and MMRRC. Finally, another group has
shown normal cocaine locomotor behavioral responses in D2-
GFP hemizygotes (Kim et al., 2011). Thus, future studies using
proper controls and proper genotypes must be performed to
fully characterize the various cell-type-speciﬁc transgenic lines
available.
GLUTAMATE AND GABA SIGNALING IN D1 VS. D2 MSNs
Medium spiny neurons receive glutamatergic input from mul-
tiple brain regions including prefrontal cortex, amygdala, and
hippocampus, and GABAergic input from local interneurons and
perhaps collateral inputs from other MSNs. Net excitatory and
inhibitory regulation of MSNs is no doubt crucial in regulating
the drug-addicted state, and there is now a growing literature on
the complex ways in which drugs of abuse alter glutamatergic
neurotransmission in particular in the NAc (Pierce et al., 1996;
Thomas et al., 2001; Beurrier and Malenka, 2002; Kourrich et al.,
2007; Bachtell and Self, 2008; Bachtell et al., 2008; Conrad et al.,
2008; Kalivas, 2009; Wolf, 2010). Although MSNs are thought to
primarily exist in an inhibited down-state under basal conditions
with glutamate driving activity of both cell-types, there remains
limited information with respect to distinct regulation occurring
in D1 vs. D2 MSNs.
FosB overexpression in D1+ MSNs (see below for more
details) enhances the rewarding effects of cocaine and increases
levels of the Ca2+-impermeable glutamate receptor subunit,
GluR2, in NAc. Furthermore, viral-mediated gene transfer of
GluR2 to the NAc similarly enhances the rewarding effects of
cocaine (Kelz et al., 1999). However, it is not known whether
the induction of GluR2 seen in response to FosB overexpres-
sion in D1+MSNs is also speciﬁc to these neurons, and the viral
overexpression of GluR2 is not cell-type-speciﬁc, thereforewe can-
not infer direct conclusions about GluR2 function in these two
MSNs in drug reward. Heusner and Palmiter (2005) assessed the
role of NMDA glutamatergic conductance in cocaine behaviors
by expressing an NR1 subunit, which contains a mutation in the
pore that reduces calcium ﬂux, selectively in D1+ MSNs. This
group showed that lack of NMDA conductance in D1+ MSNs
prevents cocaine-induced CPP and cocaine locomotor sensitiza-
tion, highlighting the necessity for NMDA signaling inD1+MSNs
for the rewarding and sensitizing effects of cocaine (Heusner and
Palmiter, 2005). Furthermore, recently it was found that knock-
ing out the NR1 subunit in D1+ MSNs attenuates amphetamine
sensitization and this phenotype was rescued by resupplying the
NR1 subunit to D1+MSNs speciﬁcally in the NAc (Beutler et al.,
2011). Finally, knockdown of the mGluR5 subunit, using RNA
interference, in D1+MSNs has no effect on the initial rewarding
properties of cocaine but diminishes the cue-induced reinstate-
ment of cocaine seeking (Novak et al., 2010). While these data
reveal compelling roles for glutamatergic signaling in D1+MSNs,
future work is needed to study glutamatergic systems in D2+
MSNs. Future research should also evaluate how modulation of
these glutamate receptor subunits in the twoMSN subtypes affects
the structural synaptic changes observed in NAc after drugs of
abuse (Dietz et al., 2009; Russo et al., 2010), particularly the den-
dritic alterations observed after cocaine exposure selectively in
the D1+ MSNs (Lee et al., 2006; Kim et al., 2011) which may be
associated with the increase in miniature excitatory postsynaptic
currents observed in D1+MSNs (Kim et al., 2011). Interestingly,
FosB induction in D1+MSNs has been related directly to such
dendritic adaptations after chronic cocaine (Maze et al., 2010).
In contrast to glutamate, there is a lack of research on GABA
function in the twoMSNs in addictionmodels,which is surprising
Frontiers in Neuroanatomy www.frontiersin.org July 2011 | Volume 5 | Article 41 | 4
Lobo and Nestler Striatal balancing act in addiction
considering both ethanol and benzodiazepines enhance the effects
of GABA and the two MSNs receive dense GABAergic inputs
as stated above. There is also considerable evidence pointing to
enhanced inhibition in theNAc at least after chronic cocaine expo-
sure (White et al., 1995; Peoples et al., 1998; Zhang et al., 1998;
Thomas et al., 2001; Beurrier and Malenka, 2002). Heiman et al.
(2008) performed high throughput genetic screening in the two
MSNs after chronic cocaine exposure and, interestingly, the most
altered biological process in the D1+MSNs was GABA signaling.
In particular, there was potent upregulation of GABAA receptor
subunits Gabra1 and Gabra4 as well as the GABAB receptor sub-
unit Gabrb3, and this group found that chronic cocaine increases
the frequency of small-amplitude GABAergic mini inhibitory
postsynaptic currents (mIPSCs) in D1+ MSNs (Heiman et al.,
2008). On the other hand, another group recently showed that
chronic cocaine results in an opposite response with decreased
frequency and amplitude of mIPSCs in the D1+ MSNs (Kim
et al., 2011). However, the latter group did show diminishedmem-
brane excitability in the D1+ MSNs after chronic cocaine, which
could be a reﬂection of enhanced GABA tone and is consistent
with the ﬁeld’s assessment of enhanced inhibition in the NAc
after exposure to chronic cocaine. Furthermore, such differences
between the two groups could simply be due to the timing of
cocaine exposure and withdrawal. In general, there is a need to
study glutamatergic and GABAergic function in the two MSNs in
response to drugs of abuse and the ﬁeld is now equipped with
the resources that make such a cell-type- and region-speciﬁc study
possible.
OTHER RECEPTOR SIGNALING IN D1 VS. D2 MSN SUBTYPES
The two MSNs are differentially enriched in other G-protein-
coupled receptors in addition to dopamine receptors. D1+MSNs
express higher levels of the acetylcholine muscarinic receptor 4
(M4; Bernard et al., 1992; Ince et al., 1997) and D2+ MSNs
are enriched in both adenosine receptor 2A (A2A; Schiffmann
et al., 1991; Schiffmann andVanderhaeghen, 1993) andG-protein-
coupled receptor 6 (Gpr6; Lobo et al., 2007; gensat.org). M4 is
coupled to Gi/o, which would produce an opposite response, com-
pared to D1 receptors, in D1+ MSNs by inhibiting cAMP/PKA
activity. Indeed, a D1+ MSN selective M4 knockout displayed
enhanced behavioral sensitization to cocaine and amphetamine
(Jeon et al., 2010). Furthermore, recent studies using a designer
receptor exclusively activated by a synthetic drug (DREADDs)
showed that activation of the DREADD Gi/o-coupled human
M4 receptor (hM4D) in D1+ MSNs diminished behavioral sen-
sitization to amphetamine, with the opposite response seen in
D2+ MSNs (Ferguson et al., 2011). Such data reveal the antag-
onizing role of M4 receptors in D1+ MSNs in drug abuse. As
well, since the hM4D receptor potently inhibits these MSNs,
the data provide insight into the effect of altered activity of
these two MSNs in drug abuse, which will be discussed further
below.
Both A2A and Gpr6 are positively coupled to Gs/Golf pro-
teins, implicating their role in antagonizing the D2-receptor in
D2+MSNs. Indeed, stimulation of A2A receptors has been shown
to reduce both the development and expression of cocaine sen-
sitization (Filip et al., 2006), impair the initiation of cocaine
self-administration (Knapp et al., 2001), and antagonize the rein-
statement of cocaine seeking elicited by cocaine,D2-receptor stim-
ulation, or cocaine-conditioned cues (Bachtell and Self, 2009). As
Gpr6 is also enriched in D2+MSNs (Lobo et al., 2007), its role in
behavioral functions of the striatum should be evaluated. To date,
it has been shown to inﬂuence instrumental learning (Lobo et al.,
2007) but its role in drug abuse models is yet unknown.
The cannabinoid receptor 1 (CB1) is expressed ubiquitously
throughout the central nervous system (Mackie, 2008), hence it
is difﬁcult to dissect the precise role of speciﬁc brain regions and
cell-types in mediating 9-tetrahydrocannabinol (THC) addic-
tion. Recently, deletion of CB1 from D1+ MSNs was found to
modestly affect behavioral responses to THC, including blunted
effects in THC-induced hypolocomotion, hypothermia, and anal-
gesia (Monory et al., 2007). It would be interesting to evaluate
cannabinoid receptor function in D2+ MSNs since these MSNs
express endocannabinoid-mediated long-term depression (eCB-
LTD), which requires dopamine D2-receptor activation (Kreitzer
and Malenka, 2007).
The glucocorticoid receptor,Nr3c1, is also broadly expressed in
the CNS and periphery. Stress-induced glucocorticoid secretion
can potentiate maladaptive behaviors including drug addiction
(Frank et al., 2011). In particular, disrupting glucocorticoid signal-
ing in D1+ MSNs by deleting Nr3c1 diminished the motivation
these mice display to self-administer cocaine, and this is consis-
tent with previous data where Nr3c1 was deleted from the entire
brain (Ambroggi et al., 2009). These data are consistent with other
ﬁndings described in this review, showing a predominant role for
D1+MSNs in mediating many of the effects of drugs of abuse.
Finally, we recently disrupted BDNF signaling in the twoMSNs
by deleting its TrkB receptor selectively from each MSN sub-
type. We observed opposite effects on cocaine-elicited behaviors:
cocaine-induced locomotor activity and the induction of cocaine
CPP were enhanced after TrkB deletion from D1+ MSNs, but
attenuated after deletion from D2+ MSNs (Lobo et al., 2010).
Interestingly, the deletion of TrkB from D2+ MSNs mimics the
effects of total deletion of TrkB from the NAc as well as dis-
ruption of BDNF signaling from the VTA (Horger et al., 1999;
Graham et al., 2007, 2009; Bahi et al., 2008; Crooks et al., 2010).
These ﬁndings thus show for the ﬁrst time a predominant role of
a signaling cascade in D2+ MSNs in mediating the effects of a
drug of abuse. The predominant role of D2+ MSNs in mediat-
ing BDNF’s effects on cocaine-elicited behaviors is not surprising
considering both TrkB mRNA and protein are enriched in D2+
MSNs (Lobo et al., 2010; Baydyuk et al., 2011). The behavioral
changes observed in these mice were accompanied by enhanced
neuronal activity in the D2+ MSNs upon a selective knockout
of TrkB. These ﬁndings prompted us to use optogenetic technol-
ogy to selectively manipulate MSN activity in cocaine reward (see
below).
TRANSCRIPTION FACTORS IN D1 VS. D2 MSNs
The most compelling evidence for the more robust role of D1+
MSNs in drug abuse comes from literature evaluating induc-
tion of intracellular signaling molecules. As stated above, acute
doses of psychostimulants induce IEG expression, including c-
Fos, Zif268 (Egr1), and FosB primarily in D1+ MSNs in NAc
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and dStr (Robertson et al., 1991; Young et al., 1991; Berretta
et al., 1992; Cenci et al., 1992; Moratalla et al., 1992; Bertran-
Gonzalez et al., 2008). This induction requires activation of D1
receptors, and the cell-type-speciﬁcity of the IEG induction in
response to acute cocaine was recently conﬁrmed using D1-GFP
and D2-GFP reporter mice (Bertran-Gonzalez et al., 2008). Inter-
estingly, the conﬁrmation of cocaine’s induction of c-Fos primarily
in D1-GFP throughout striatum with a small induction in D2-
GFPMSNs only in dStr was conﬁrmed using a context-dependent
paradigm (mice were injected in a novel environment outside of
their home cage). Furthermore, a previous study using in situ
hybridization in mice also showed induction of c-Fos in D1+
and D2+MSNs in dStr, although in this study representative bar
graphs show greater number of D1+ c-Fos positive neurons (Fer-
guson et al., 2006). Interestingly, this study reveals signiﬁcantly
enhanced c-Fos induction in D2+ MSNs in the dStr after loss of
ERK1,which parallels our ﬁndings of enhanced c-Fos induction in
D2+MSNs speciﬁcally in the NAc shell after disruption of BDNF
signaling which is known to enhance ERK activity (Lobo et al.,
2010). However, opposite behavioral responses to cocaine were
observed in each study, which may reﬂect induction of c-Fos in
D2+MSNs in dStr vs. NAc shell. Finally, previous literature using
in situ hybridization/immunohistochemistry in rats has shown
acute psychostimulants can induce c-Fos equally in both MSNs
when the drug is given in a novel environment (Badiani et al.,
1999; Uslaner et al., 2001a,b; Ferguson and Robinson, 2004) and
chronic administration of amphetamine is reported to selectively
induce c-Fos in D2+ MSNs (Mattson et al., 2007). These differ-
ent results could be a reﬂection of the experimental procedures
used (in situ hybridization vs. GFP reporter mice) or even be
due to the animal species used as the latter experiments used
rats.
Recently, researchers genetically proﬁled the cocaine context-
dependent, c-Fos activated neurons in rats using immunolabeled
ﬂuorescence activated cell sorting (FACS) and showed that the
c-Fos+ neurons are enriched in a D1+MSN gene, prodynorphin
(Pdyn), but have lower levels of D2 andA2A, both D2+MSN genes
(Guez-Barber et al., 2011), suggesting that the c-Fos+ activated
neurons consist primarily of D1+MSNs. Furthermore, this group
previously showed that c-Fos expressing MSNs are important for
this context-dependent sensitization, as ablation of these neurons
abolishes this behavioral phenotype (Koya et al., 2009). Although
previous data showed that the cocaine context-dependent induc-
tion of c-Fos occurs in both D1+ and D2+ MSNs in rats, the
more recent results correspond to ﬁndings in which deletion of
c-Fos selectively from D1+ MSNs blunts cocaine-induced loco-
motor sensitization in mice (Zhang et al., 2006). Furthermore,
this group found that deletion of c-Fos in D1+MSNs blunts the
dendritic spine changes normally induced by cocaine in the NAc,
indicating a role for c-Fos in mediating these synaptic plasticity
changes. Finally, the group observed no change in the induction
of cocaine CPP, but found that loss of c-Fos in D1+ MSNs pre-
vented extinction of cocaine CPP. Such data illustrate a dynamic
role for c-Fos induction in D1+MSNs, however, one cannot rule
out the differential effects at the behavioral level as beingmediated
by any of several other limbic brain regions that express the D1
receptor.
Another IEG that has been extensively studied in the two MSN
subtypes is FosB. Acute exposure to cocaine induces FosB in D1+
MSNs (Berretta et al., 1992), whereas chronic exposure induces
FosB, a stable product of the FosB gene generated by alternative
splicing (Hope et al., 1994; Nestler et al., 2001; Nestler, 2008), in
D1+MSNs (Nye et al., 1995;Moratalla et al., 1996; Lee et al., 2006).
Similar ﬁndings are observed with many other drugs of abuse as
well as with natural rewards such as food, sex, and wheel running.
For example, chronic wheel running, which is a natural reward
(Iversen, 1993; Belke, 1997; Lett et al., 2000), induces FosB in
D1+ MSNs but not D2+ MSNs (Werme et al., 2002). To gain
functional insight into the role of FosB in the two MSNs, our
group generated NSE-tTa lines, termed 11A and 11B, which direct
transgene expression to either D1+ or D2+ MSNs, respectively
(Chen et al., 1998; Kelz et al., 1999; Werme et al., 2002). Line 11A
mice crossed with a Tet-Op FosB line show increased responses
to the rewarding and locomotor effects of cocaine (Kelz et al.,
1999), which is consistent with FosB induction in D1+ MSNs
(Nye et al., 1995; Moratalla et al., 1996). Furthermore, these same
mice display increased morphine reward (evaluated by CPP) as
well as diminished morphine analgesia and enhanced morphine
tolerance, while the 11B Tet-Op FosB mice show no change in
morphine reward. Overexpression of a dominant negative antag-
onist of FosB exerts effects opposite to those seen with FosB,
although this mouse model does not distinguish D1 vs. D2 MSNs
(Peakman et al., 2003). Together, these data further supports the
role ofFosB induction in D1+MSNs as an important molecular
player in the rewarding properties of drugs of abuse (Zachariou
et al., 2006). This phenomenon is also observed in other reward
behaviors, in particular, wheel running: 11A Tet-Op FosB mice
display increased wheel running behavior, whereas 11B Tet-Op
FosB mice display diminished wheel running (Werme et al.,
2002). The ﬁnding that FosB induction in D1 MSNs promotes
reward is consistent with recent ﬁndings that such cell-type-
selective induction also promotes resilience responses to chronic
stress (Vialou et al., 2010). Finally, chronic cocaine induction of
FosB in D1+ MSNs was shown to be accompanied by robust
long-lasting increases in dendritic spine densities (Lee et al., 2006)
and recentlyFosB in theNAcwas shown to be bothnecessary and
sufﬁcient in mediating the increased density of dendritic spines in
this brain region (Maze et al., 2010). Such data support a role for
FosB in D1+MSNs in mediating the rewarding aspects of drugs
of abuse and natural rewards as well as the accompanying struc-
tural plasticity changes. The data also suggest that induction of
FosB in D2+MSNs confers negative consequences to rewarding
stimuli. SinceFosB induction in D2+MSNs is seen in response
to chronic stress and antipsychotic drug exposure (Hiroi andGray-
biel, 1996; Perrotti et al., 2004), further studies of the latter actions
are needed.
OTHER INTRACELLULAR SIGNALING MOLECULES IN D1 VS.
D2 MSNs
One signalingmolecule that has beenwell studied in the twoMSNs
in the context of drug abuse is the protein kinase, ERK (extracel-
lular signal related kinase). Acute or chronic exposure to cocaine
induces phosphorylated ERK (pERK), the activated form of the
protein, in the NAc and dStr in D1+ MSNs using D1-GFP and
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D2-GFP BAC transgenic reporter mice (Bertran-Gonzalez et al.,
2008) and this response is mediated through D1 receptors (Val-
jent et al., 2000; Lu et al., 2006). This group also showed that
pMSK-1 (phospho-MAP and stress activated kinase-1) and his-
tone H3, both targets of pERK signaling, are robustly induced in
pERK containing D1+ MSNs after acute cocaine exposure and
modestly increased after chronic cocaine (Bertran-Gonzalez et al.,
2008). pERK is also induced is response to chronic morphine, in
particular, pERK is robustly induced in D1+ MSNs and mod-
estly induced in D2+ MSNs in the NAc shell after withdrawal
in response to the context-speciﬁc association with morphine
(Borgkvist et al.,2008). Theprecise functional role of pERK indrug
addiction remains to be determined. Pharmacological treatment
with ERK inhibitors has been shown to decrease cocaine reward,
however, a knockout of ERK1 potentiates cocaine reward, sug-
gesting that ERK inhibitors may preferentially be affecting ERK2.
Recently, we showed that optogenetic activation of D1+ MSNs
in the NAc, which increases an animal’s rewarding responses to
cocaine, potently reduces both pERK1 and pERK2. Future studies
manipulating ERK expression in a cell-type-speciﬁc manner are
necessary to fully address the functional role of ERK signaling in
the two MSNs in drug abuse.
DARPP-32 is another signaling molecule that has been exten-
sively studied in response to drugs of abuse. It is well known that
acute psychostimulants lead to PKA phosphorylation of DARPP-
32 at threonine 34 (T34), causing it to become a potent inhibitor
of protein phosphatase 1 (PP-1), which regulates the phospho-
rylation state of many effector proteins, including transcription
factors, ionotropic receptors, and ion channels (Greengard et al.,
1999). However, until recently, it was unclear which MSN subtype
mediates this biochemical change. Greengard et al. (1999) gener-
ated BAC transgenic mouse models that enable the evaluation of
DARPP-32 phosphorylation in D1+ or D2+ MSNs by express-
ing tagged versions of DARPP-32 using D1 or D2 BACs allowing
for immunoprecipitation of DARPP-32 from each MSN subtype.
These studies demonstrated that acute cocaine treatment increases
T34 phosphorylation in D1+MSNs and induces phosphorylation
of threonine 75 (T75) by Cdk5, which inhibits PKA signaling,
selectively in D2+ MSNs (Bateup et al., 2008). Finally this group
showed that deletion of DARPP-32 from eachMSN subtype using
D1-Cre and D2-Cre BAC transgenic mice results in opposite regu-
lation of cocaine-induced locomotor activity (Bateup et al., 2010).
Loss of DARPP-32 from D1+ MSNs diminished the locomo-
tor effects of cocaine, which mimics previous data evaluating a
total DARPP-32 knockout (Fienberg et al., 1998), whereas loss
of DARPP-32 from D2+ MSNs enhanced cocaine locomotor
responses. Such data provide concrete evidence for differential
roles of DARPP-32 in the twoMSNs in response to drugs of abuse
and illustrate the importance of cell-type-speciﬁcmethods to fully
understand the contribution of these two neuronal types in drug
addiction.
MODULATING ACTIVITY OF D1 OR D2 MSNs
Directly modulating the activity of the two MSN subtypes has
recently provided novel insight into the molecular and func-
tional role of D1 and D2 MSNs in addiction. We used opto-
genetic tools combined with a conditional (i.e., Cre-dependent)
adeno-associated viral (AAV) vector expressing the blue light-
activated cation channel, channelrhodopsin-2 (ChR2). We
injected the vector, or a control, into the NAc of D1-Cre or D2-
Cre BAC transgenic mice and then stimulated the injected region
with blue light to selectively activate D1+ vs. D2+ MSNs in the
context of cocaine CPP. We found that activation of D1+ MSNs
potentiates induction of cocaine CPP, whereas activation of D2+
MSNs inhibits this induction (Lobo et al., 2010). As noted pre-
viously, we observed the same behavioral effects when TrkB was
deleted selectively from these MSN subtypes: enhanced cocaine
CPP and locomotor activity after TrkB deletion from D1+MSNs,
and reduced cocaine CPP and locomotor activity after TrkB dele-
tion fromD2+MSNs.The likely commonactionof TrkBknockout
and optogenetic stimulation inD2+MSNs is their increased activ-
ity, since deletion of TrkB from these cells increases their electrical
excitability. As mentioned earlier, we also found a robust reduc-
tion of pERK after TrkB deletion from D1+ MSNs. pERK is
a known downstream target of BDNF signaling, therefore, the
shared behavioral effects observed after TrkB deletion from D1+
MSNs and from optogenetic activation of these cells might be
due to converging effects on pERK activity. However, future work
is needed to determine the precise, shared molecular underpin-
nings that govern the behavioral effects seen after disruption of
BDNF signaling and optogenetic control of these two neuronal
subtypes.
Other groups have used different tools to modulate activity of
the twoMSNs in drug abusemodels. Hikida et al. (2010) usedAAV
vectors to express tetracycline-repressive transcription factor (tTa)
using the substance P (a D1+ MSN gene) or enkephalin (a D2+
MSN gene) promoters. These vectors were injected into the NAc
of mice, in which tetanus toxin light chain (TN) – a bacterial toxin
that cleaves the synaptic vesicle-associated protein, VAMP2 – was
controlled by the tetracycline-responsive element, to selectively
abolish synaptic transmission in each MSN subtype. Consistent
with our optogenetic approach, these data showed a role of D1+
MSNactivity in enhancing cocaineCPP aswell as cocaine-induced
locomotor activity, since abolishing synaptic transmission in D1+
MSNs diminished both behavioral effects. In contrast to the opto-
genetic studies, the authors found no alterations in cocaine CPP
after abolishing synaptic transmission in D2+ MSNs, but did
observe reduced cocaine-induced locomotor activity in response
to the ﬁrst two cocaine exposures. Interestingly, this group showed
that inactivation of the D2+ MSNs played a more profound role
in mediating aversive behaviors.
As stated earlier, Ferguson et al. (2011) used herpes sim-
plex virus (HSV) vectors to express an engineered GPCR (a
Gi/o-coupled human muscarinic M4 designer receptor exclusively
activated by a designer drug, hM4D) that is activated by an other-
wise pharmacologically inert ligand using enkephalin and dynor-
phin promoters to selectively silence D1+ or D2+ MSNs in the
dStr. The authors showed that transiently disrupting D2+ MSN
activity in dStr facilitated amphetamine sensitization, whereas
decreasing excitability of D1+ MSNs impaired the persistence
of amphetamine-induced sensitization. Finally, abolishing D2+
MSNs in the NAc at adult ages using diptheria toxin receptor
enhances the rewarding effect of amphetamine (Durieux et al.,
2009). Such data are in accordance with our optogenetic ﬁndings,
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and together implicate opposite roles of D1+ vs. D2+ MSNs in
drug addiction, with D1+MSNs promoting both reward and sen-
sitizing responses to psychostimulants andD2+MSNsdampening
these behaviors.
FUTURE DIRECTIONS
The ﬁeld has made tremendous advances toward understanding
the selective role of the D1+ and D2+ MSN subtypes in NAc
and dStr in mediating the effects of drugs of abuse. In particular,
recently developed tools that enable the selective manipulation of
these cell-types have played a predominant role in obtaining the
majority of this information. What are the next steps? Since the
underlying molecular adaptations in drug addiction models are
not static, but very dynamic, it is crucial to develop the capability
to selectivelymanipulate signalingmolecules of interest inD1+ vs.
D2+ MSNs in a temporally precise way. DREADDs and optoge-
netic tools can help with this time scale manipulation. DREADD
ligands can be administered at different time courses throughout
drug behavioral paradigms to parcel out the selective role of sig-
naling receptors in the two MSNs in drug models. Optogenetic
tools in particular provide an extremely powerful means to tem-
porally regulate not only neuronal activity but G-protein-coupled
receptor signaling using OptoXRs (Airan et al., 2009), glutamater-
gic signaling(Volgraf et al., 2006; Numano et al., 2009),GABAergic
signaling, and even certain intracellular signaling molecules (Wu
et al., 2009; Hahn and Kuhlman, 2010). Ultimately, it may be
possible to extend these capabilities to optogenetic regulation of
transcriptional activity. Likewise, optogenetic tools are making it
possible for the ﬁrst time to study the inﬂuence of speciﬁc inputs
to striatum and to determine whether such inputs impinge in
selective ways on D1+ vs. D2+MSNs (Higley and Sabatini, 2010).
The ability to control such signaling andmolecular properties with
great temporal resolutionwill allowmajor steps to bemade toward
a more comprehensive understanding of the two MSN subtypes,
and other cell subtypes in NAc and dStr, in mediating the time
course and different phases of drug addiction.
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